VIA
SRNE

Vident Investment Advisory’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Vident Investment Advisory’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-320,492
Closed -$1.41M – 955
2018
Q3 		$1.41M Sell
320,492
-21,360
-6% -$118K 0.06% 396
2018
Q2 		$2.46M Buy
+341,852
New +$2.33M 0.1% 282
2017
Q2 		– Sell
-170,534
Closed -$674K – 456
2017
Q1 		$674K Buy
170,534
+28,420
+20% +$143K 0.07% 328
2016
Q4 		$696K Buy
+142,114
New +$854K 0.08% 314

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return